Active Implants Secures First Tranche of $40 Million Equity Financing

Active Implants completed the first US $10MM tranche of a $40MM Class D Units financing. Funds will support two ongoing clinical trials of the NUsurface® Meniscus Implant, a polymer-based investigational treatment for persistent knee pain following medial meniscus surgery.

Enrollment for the SUN and VENUS trials is expected to be complete by...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us